{"result": "(\"entity\"<|>NUTRICIÓN ARTIFICIAL<|>EVENT<|>Nutritional support provided to patients through artificial means, which is a central theme in the discussion of hyponatremia.)\n##\n(\"entity\"<|>FISIOPATOLOGÍA DE LA HIPONATREMIA<|>EVENT<|>The pathophysiology of hyponatremia, which is discussed in the context of patients receiving artificial nutrition.)\n##\n(\"entity\"<|>MANIFESTACIONES CLÍNICAS DE LA HIPONATREMIA<|>EVENT<|>Clinical manifestations of hyponatremia, which are outlined in the study regarding patients with artificial nutrition.)\n##\n(\"entity\"<|>DIAGNÓSTICO Y ETIOLOGÍA DE LA HIPONATREMIA<|>EVENT<|>Diagnosis and etiology of hyponatremia in patients receiving artificial nutrition, which is a key focus of the study.)\n##\n(\"entity\"<|>TRATAMIENTO DE LA HIPONATREMIA<|>EVENT<|>Treatment of hyponatremia in the context of artificial nutrition, which is discussed in the study.)\n##\n(\"relationship\"<|>NUTRICIÓN ARTIFICIAL<|>HIPONATREMIA<|>Hyponatremia is a condition that can occur in patients receiving artificial nutrition, making it a relevant topic of study.<|>8)\n##\n(\"relationship\"<|>FISIOPATOLOGÍA DE LA HIPONATREMIA<|>HIPONATREMIA<|>The pathophysiology of hyponatremia explains the underlying mechanisms of the condition, which is crucial for understanding its impact on patients receiving artificial nutrition.<|>7)\n##\n(\"relationship\"<|>MANIFESTACIONES CLÍNICAS DE LA HIPONATREMIA<|>HIPONATREMIA<|>The clinical manifestations of hyponatremia provide insight into how the condition presents in patients, particularly those on artificial nutrition.<|>7)\n##\n(\"relationship\"<|>DIAGNÓSTICO Y ETIOLOGÍA DE LA HIPONATREMIA<|>HIPONATREMIA<|>The diagnosis and etiology of hyponatremia are essential for identifying and managing the condition in patients receiving artificial nutrition.<|>7)\n##\n(\"relationship\"<|>TRATAMIENTO DE LA HIPONATREMIA<|>HIPONATREMIA<|>The treatment of hyponatremia is critical for managing patients who experience this condition while on artificial nutrition.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 42. Hegazi RA, Hustead DS, Evans DC. Preoperative\n    standard oral nutrition supplements vs immuno-\n    nutrition: results of a systematic review and me-\n    ta-analysis. J Am Coll Surg. 2014; 219:1078-87.\n43. De Bandt JP, Coudray-Lucas C, Lioret N. A rando-\n    mised controlled trial of the influence of the mode\n    of enteral ornithine trial of the influence of the\n    mode of enteral ornithine a–ketogluturare admi-\n    nistration in burn patients. J Nutr 1998; 128:563-\n    569.\n44. Maung AA, Davis KA. Perioperative nutritional su-\n    pport: immunonutrition, probiotics, and anabolic\n    steroids. Surg Clin North Am. 2012; 92:273-83.\n45. Berger A. What does zinc do? BMJ 2002; 325:1062.\n46. Yang F, Oz S, Barve S. The green tea polyphenol\n    epigallocatechin-3-gallate blocks nuclear factor\n    kappa beta activation by inhibiting I kappa B kina-\n    se activity in the intestinal epithelial cell line IEC-6.\n    Mol Pharmacol 2001; 60:528-533.\n\n47. Heyland DK, Novak F, Drover JW, Jain M, Su X,\n    Suchner U. Should immunonutrition become rou-\n    tine in critically ill patients: A systematic review of\n    the evidence. JAMA 2001; 286:944-953.\n48. Montejo JC, Zarazaga, Lopez Martinez J. Immuno-\n    nutrition in the intensive care unit, a systematic\n    review and consensus statement. Clinical Nutrition\n    2003; 22:221-233.\n49. ASPEN Board of Directors and the Clinical Guideli-\n    nes Task Force. Guidelines for the use of parenteral\n    and enteral nutrition in adult and pediatric pa-\n    tients. JPEN 2002; 26 (Supp).\n50. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek\n    P and the Canadian Critical Care Clinical Practice Gui-\n    delines Committee. Canadian Clinical Practice Guideli-\n    nes for Nutrition Support in Mechanically Ventilated.\n    Critically Adult Patients. JPEN 2003; 27:355-73.\n51. Dewey A. EPA (an omega 3 fatty acid from fish\n    oils) for the treatment of cancer cachexia. Cochra-\n    ne Database Syst Rev. 2007 Jan 24;(1):CD004597.\n52. Valentini L, Schütz T, Allison S, Howard P, Pichard\n    C, Lochs H. ESPEN Guidelines on enteral nutrition.\n    Clin Nutr. 2006;25:260-74.\n53. Bharadwaj S, Trivax B, Tandon P, Alkam B, Hanou-\n    neh I, Steiger E. Should perioperative immunonu-\n    trition for elective surgery be the current standard\n    of care?Gastroenterol Rep (Oxf). 2016; 4:87-95.\n54. Wong CS, Aly EH. The effects of enteral immuno-\n    nutrition in upper gastrointestinal surgery: A syste-\n    matic review and meta-analysis. Int J Surg. 2016;\n    29:137-50.\n55. Mauskopf JA. Immunonutrition fo patients under-\n    going elective surgery for gastrointestinal cáncer:\n    impacto n hospital costs. World J Surg Oncol\n    2012; 10:136.\n56. Celik JB, Gezginç K, Ozçelik K, Celik C. The role of\n    immunonutrition in gynecologic oncologic sur-\n    gery. Eur J Gynaecol Oncol. 2009; 30:418-21.\n57. Jafari T, Feizi A, Askari G, Fallah AA. Parenteral im-\n    munonutrition in patients with acute pancreatitis:\n    a systematic review and meta-analysis. Clin Nutr.\n    2015; 34:35-43.\n---\n# Tema 51.\n## Metabolismo hídrico en los pacientes con nutrición artificial: importancia y tratamiento de la hiponatremia\n\nEmilia Gómez Hoyos\nAna Ortolá Buigues\nJuan José López Gómez\nBeatriz Torres Torres\nDaniel Antonio De Luis Román\nServicio de Endocrinología y Nutrición. Hospital Clínico Universitario de Valladolid\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 799-817.\n\n1. Introducción\n2. Fisiopatología de la hiponatremia\n3. Manifestaciones clínicas de la hiponatremia\n4. Diagnóstico y etiología de la hiponatremia en pacientes con nutrición artificial\n5. Tratamiento de la hiponatremia en nutrición artificial\n6. Resumen\n7. Bibliografía\n\n### 1. Introducción\n\nLa hiponatremia (disminución de la concentración sérica de sodio o nat\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>ORGANIZATION<|>The Hospital Clínico Universitario de Valladolid is a medical institution where the authors are affiliated, focusing on endocrinology and nutrition.)\n##\n(\"entity\"<|>EMILIA GÓMEZ HOYOS<|>PERSON<|>Emilia Gómez Hoyos is one of the authors of the study on water metabolism in patients with artificial nutrition.)\n##\n(\"entity\"<|>ANA ORTOLÁ BUIGUES<|>PERSON<|>Ana Ortolá Buigues is a co-author of the study on water metabolism in patients with artificial nutrition.)\n##\n(\"entity\"<|>JUAN JOSÉ LÓPEZ GÓMEZ<|>PERSON<|>Juan José López Gómez is a co-author of the study on water metabolism in patients with artificial nutrition.)\n##\n(\"entity\"<|>BEATRIZ TORRES TORRES<|>PERSON<|>Beatriz Torres Torres is a co-author of the study on water metabolism in patients with artificial nutrition.)\n##\n(\"entity\"<|>DANIEL ANTONIO DE LUIS ROMÁN<|>PERSON<|>Daniel Antonio De Luis Román is a co-author of the study on water metabolism in patients with artificial nutrition.)\n##\n(\"entity\"<|>HIPONATREMIA<|>EVENT<|>Hyponatremia is a medical condition characterized by low sodium concentration in the blood, which is discussed in the context of patients receiving artificial nutrition.)\n##\n(\"relationship\"<|>EMILIA GÓMEZ HOYOS<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Emilia Gómez Hoyos is affiliated with the Hospital Clínico Universitario de Valladolid as a researcher in endocrinology and nutrition.<|>8)\n##\n(\"relationship\"<|>ANA ORTOLÁ BUIGUES<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Ana Ortolá Buigues is affiliated with the Hospital Clínico Universitario de Valladolid as a researcher in endocrinology and nutrition.<|>8)\n##\n(\"relationship\"<|>JUAN JOSÉ LÓPEZ GÓMEZ<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Juan José López Gómez is affiliated with the Hospital Clínico Universitario de Valladolid as a researcher in endocrinology and nutrition.<|>8)\n##\n(\"relationship\"<|>BEATRIZ TORRES TORRES<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Beatriz Torres Torres is affiliated with the Hospital Clínico Universitario de Valladolid as a researcher in endocrinology and nutrition.<|>8)\n##\n(\"relationship\"<|>DANIEL ANTONIO DE LUIS ROMÁN<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Daniel Antonio De Luis Román is affiliated with the Hospital Clínico Universitario de Valladolid as a researcher in endocrinology and nutrition.<|>8)\n##\n(\"relationship\"<|>HIPONATREMIA<|>EMILIA GÓMEZ HOYOS<|>Emilia Gómez Hoyos is a co-author discussing the condition of hyponatremia in the context of artificial nutrition.<|>7)\n##\n(\"relationship\"<|>HIPONATREMIA<|>ANA ORTOLÁ BUIGUES<|>Ana Ortolá Buigues is a co-author discussing the condition of hyponatremia in the context of artificial nutrition.<|>7)\n##\n(\"relationship\"<|>HIPONATREMIA<|>JUAN JOSÉ LÓPEZ GÓMEZ<|>Juan José López Gómez is a co-author discussing the condition of hyponatremia in the context of artificial nutrition.<|>7)\n##\n(\"relationship\"<|>HIPONATREMIA<|>BEATRIZ TORRES TORRES<|>Beatriz Torres Torres is a co-author discussing the condition of hyponatremia in the context of artificial nutrition.<|>7)\n##\n(\"relationship\"<|>HIPONATREMIA<|>DANIEL ANTONIO DE LUIS ROMÁN<|>Daniel Antonio De Luis Román is a co-author discussing the condition of hyponatremia in the context of artificial nutrition.<|>7)\n<|COMPLETE|>"}]}